Dry needling is the insertion of a fine solid monofilament needle into a myofascial trigger point or other soft tissue target without injecting anything, which is what the word dry refers to. It is used mainly for myofascial pain, usually alongside exercise and manual therapy rather than as a treatment in its own right, and it is widely practised in sport and exercise medicine (SEM) by doctors, physiotherapists and other trained clinicians. The needles are the same fine filiform needles used in acupuncture, but the reasoning is different: dry needling is framed in Western anatomical and neurophysiological terms and usually targets a clinically identified myofascial trigger point or other symptomatic soft-tissue target, whereas acupuncture in its traditional form is guided by a different explanatory system, although terminology, techniques and theoretical models overlap considerably between the two. This page covers the technique, what the evidence supports, and the safety issues that matter most.
How is dry needling performed?
The target is usually a myofascial trigger point, a tender nodule within a palpable taut band of muscle that reproduces the patient's familiar pain when pressed. The clinician locates the band by palpation, fixes it between the fingers, and advances a fine solid needle through the skin into the nodule. Needle diameters are small, typically in the range used for acupuncture, and the needle is solid rather than hollow, so nothing is injected and nothing is aspirated. Two broad approaches exist. In a deep technique the needle is advanced into the trigger point itself and may be moved in and out in a controlled fashion, often provoking a local twitch response (LTR), a brief involuntary contraction of the taut band that the patient may feel as a cramp or a jolt. In a superficial technique the needle is placed in the tissue overlying the trigger point rather than within it, and superficial techniques vary in depth, dwell time and whether the needle is manipulated; they are generally less uncomfortable and are often chosen for anxious patients or sensitive areas.
A fine solid needle is advanced into a trigger point within a taut band. Brief needle movement may provoke a local twitch response, an involuntary contraction of the taut band.
The local twitch response is often described as confirming that the needle has found the trigger point, but it is better understood as suggesting engagement of the target muscle or taut band rather than confirming a distinct pathological lesion, since trigger point identification by palpation has imperfect reliability. Many clinicians treat it as the aim of a deep technique, and its necessity is debated: it is a useful sign that the target has been engaged, but whether provoking it is required for a good clinical outcome is not settled, and repeated needling to chase twitches adds discomfort and post-treatment soreness. Treatment is usually brief, and patients are told what to expect afterwards, since post-needling soreness is common. It is typically a dull ache in the treated muscle or in that muscle's referral pattern, appears within hours and usually resolves within twenty-four to forty-eight hours, although duration varies, and it is more likely where more needle insertions were used and where the procedure itself was painful. Patients are advised that this is expected rather than a complication, and that they should continue their exercise programme.
What does the evidence show, and what are the risks?
The evidence base is larger than it is convincing. Low to moderate certainty evidence suggests short-term pain benefit compared with sham or no treatment, with inconsistent functional benefit and little evidence of superiority over other active treatments. Effects are typically modest and short-lived, studies are small and often poorly blinded, sham needling is difficult to design convincingly, and comparisons against other active treatments frequently show little difference. The reasonable position is that dry needling can be a useful short-term adjunct for myofascial pain in a patient who is also doing the exercise and load management that changes outcomes, and that it should not be presented as a stand-alone treatment or as correcting a structural problem. Where a patient improves, that window is used to progress rehabilitation rather than to schedule an indefinite series of needling appointments.
Near the thorax, safety depends on identifying a bony backstop and a planned maximum depth using a muscle-specific technique, not on any single trajectory. Needling into the intercostal space risks pneumothorax.
Safety is generally good, with the great majority of adverse events mild: post-needling soreness, bruising, minor bleeding and, occasionally, a vasovagal episode. Serious events are rare but real. Pneumothorax is the key serious risk when needling the neck, shoulder girdle or thorax, and it has been reported after needling trapezius, rhomboids, levator scapulae, the paraspinal muscles and pectoral muscles; other rare serious events include neurovascular or visceral injury and infection. The protective habits are anatomical rather than a single universal trajectory. Identify the rib, the scapula, the intercostal space and the planned maximum depth before needling; use a formally taught, muscle-specific technique with a defined bony backstop; consider ultrasound where depth is uncertain, recognising that measuring skin-to-rib depth reduces uncertainty but does not guarantee safety if the needle angle or the patient's position changes; and do not needle the region at all if a safe backstop cannot be established. Techniques that aim to bracket a rib have still been associated with pneumothorax, so no trajectory should be treated as inherently safe. Other precautions apply generally: treat the patient reclined so that a faint does not cause a fall, warn them not to move while a needle is in place, use single-use sterile needles with aseptic technique and dispose of them immediately as sharps, take care around superficial nerves and vessels, and assess patients on antithrombotic treatment individually, since this is not an absolute contraindication: consider the drug and its effect, bleeding history, the depth and compressibility of the target and local policy. Local infection is a contraindication at the site, while pregnancy and lymphoedema in the limb are precautions handled according to local policy rather than universal bars. Consent should be explicit, covering the twitch sensation, expected soreness, and the rare but serious risks, including that symptoms of pneumothorax such as breathlessness and pleuritic pain may begin some hours after treatment rather than immediately.
Exam Tips
•Dry needling uses a fine solid monofilament needle with no injectate; the needles are the same as acupuncture needles but the reasoning is Western anatomical and neurophysiological rather than traditional.
•The target is a myofascial trigger point in a palpable taut band that reproduces the patient's familiar pain.
•A local twitch response (LTR) suggests engagement of the target muscle or taut band rather than confirming a distinct lesion, and whether provoking it is necessary for a good outcome remains debated.
•Low to moderate certainty evidence suggests short-term pain benefit, with inconsistent functional benefit and little evidence of superiority over other active treatments.
•Post-needling soreness is common, appears within hours and usually resolves within twenty-four to forty-eight hours, although duration varies; it is more likely with more insertions.
•Pneumothorax is the key serious risk near the neck, shoulder girdle and thorax: use a muscle-specific technique with a defined bony backstop and planned maximum depth, consider ultrasound if depth is uncertain, and do not needle if a safe backstop cannot be established.